Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors.

ABSTRACT:

SUBMITTER: Waissengrin B 

PROVIDER: S-EPMC8016402 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature